| Predicate |
Object |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G06T2207-30056
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G06T2207-30101
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G06T2207-30096
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-7028
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G06T2207-10081
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G06T2207-10088 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-532
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-533
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G06T7-90
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-57438
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G16H50-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G06T7-0012
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G16H20-40
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G16H30-40 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G06T7-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G06T7-90
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-532
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-533
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G16H30-40
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G16H20-40
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G16H50-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-574 |
| filingDate |
2019-06-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2021-12-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate |
2021-12-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
CN-110189824-B |
| titleOfInvention |
Prognostic grouping method, device and system for radical resection of primary liver cancer |
| abstract |
The invention relates to a method, device and system for grouping the prognosis of primary liver cancer radical resection, based on the combined detection of cytokeratin 19 (CK19) and glypican-3 (GPC3), the number of tumors A method for assessing the risk of postoperative recurrence in patients with primary liver cancer who plan to undergo or have undergone radical tumor resection using tumor thrombus and vascular tumor thrombus as indicators. According to this method, patients can be reasonably screened before surgery to reduce the metastasis and recurrence after radical tumor resection; The risk of recurrence can be assessed to guide clinicians to implement close monitoring and early management of cases with high risk of metastasis and recurrence. |
| priorityDate |
2019-06-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |